November 1, 2019 / 6:51 AM / 12 days ago

Drugmaker Novo Nordisk's Q3 operating profit slightly lags forecast

COPENHAGEN, Nov 1 (Reuters) - Novo Nordisk posted third-quarter operating profit a touch below expectations on Friday but nudged up its sales outlook for this year on the back of its new drugs for type 2 diabetes and obesity.

The world’s largest maker of diabetes drugs posted a quarterly operating profit of 12.9 billion Danish crowns ($1.93 billion), slightly below an average 13.1 billion crowns forecast in a Refinitiv poll of analysts.. ($1 = 6.6919 Danish crowns) (Reporting by Stine Jacobsen Editing by Shri Navaratnam)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below